Silver Coast Investments’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$355K Hold
3,710
0.11% 86
2026
Q1
$357K Sell
3,710
-581
-14% -$58.1K 0.11% 79
2025
Q4
$417K Sell
4,291
-59
-1% -$5.06K 0.14% 64
2025
Q3
$310K Hold
4,350
0.11% 85
2025
Q2
$260K Hold
4,350
0.09% 94
2025
Q1
$228K Buy
4,350
+66
+2% +$3.71K 0.09% 97
2024
Q4
$236K Buy
+4,284
New +$225K 0.09% 91

Other funds holding IRMD

Silver Coast Investments's IRMD Position: Q2 2026 in Review

Silver Coast Investments held its iRadimed (IRMD) position steady in Q2 2026 at 3,710 shares worth $355K. The position accounts for 0.11% of the portfolio, ranked #86.

Silver Coast Investments first reported a position in IRMD in Q4 2024 and has held it in 7 quarters since. The position peaked at $417K in Q4 2025. 55 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • Silver Coast Investments held 3,710 shares of iRadimed worth $355K as of Q2 2026.
  • Silver Coast Investments left its iRadimed share count unchanged in Q2 2026.
  • iRadimed made up 0.11% of Silver Coast Investments's portfolio in Q2 2026, its #86 holding.
  • Silver Coast Investments first reported a position in iRadimed in Q4 2024 and has held it in 7 quarters since.
  • Silver Coast Investments's iRadimed position peaked at $417K in Q4 2025.
  • 55 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Silver Coast Investments's 13F filing for Q2 2026, filed 24 Jul 2026.